Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.02 - Biology/Pathology
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P1.02-011 - XRCC6BP1: A Key Player in the DNA Repair of Cisplatin Resistant NSCLC Cells
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): S. Singh, R. Farrell, E. Foley, Y. He, L. Brady, V. Young, R. Ryan, S. Nicholson, N. Leonard, S. Cuffe, Stephen P Finn
- Abstract
Loading... -
+
P1.02-071a - Targeting Human Single Stranded DNA Binding Protein (hSSB) 1, a Novel Prognostic Factor, in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): D. Boucher, N. Ashton, J. Burgess, E. Bolderson, Martin P Barr, Steven G. Gray, K. Gately, L. Croft, D. Richard
- Abstract
Loading... -
+
P1.02-071b - SASH1 Is a Prognostic Indicator and Future Target in NSCLC
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): J. Burgess, E. Bolderson, Mark Adams, S. Zhang, S. Fox, G. Wright, R. Young, Ben J Solomon, Martin P Barr, Steven G. Gray, D. Richard
- Abstract
Loading...
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-039 - Therapeutic Inhibition of the Cancer Stem Cell Marker, ALDH1, a Promising Mechanism by Which Cisplatin Sensitivity Can Be Restored in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, S. Cuffe, Stephen P Finn, S. Nicholson, R. Ryan, V. Young, N. Leonard, Kenneth Obyrne
- Abstract
Loading... -
+
P1.03-041 - Exploitation of the Cancer Stem Cell Marker ALDH1 Within the Vitamin a/Retinoic Acid Axis Promotes Re-Sensitisation of Cisplatin Resistant NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, M. Gallagher, B. Ffrench, C. Gasch, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P1.03-042 - BBI608, a Small Molecule Stemness Inhibitor, Circumvents Cisplatin Resistance in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P1.03-048 - miR-34a and the Micromanagement of Cancer Stemness and Resistance in NSCLC. Does It Hold Therapeutic Benefit?
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, M. Gallagher, B. Ffrench, C. Gasch, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading...
-
+
P1.09 - Mesothelioma
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P1.09-007 - Targeting MET/TAM Receptors in Mesothelioma: Are Multi-TKIs Superior to Specific TKI?
09:30 - 09:30 | Presenter: Steven G. Gray | Author(s): Anne-Marie Baird, D. Easty, M. Jarzabek, L. Shiels, C. Wu, A. Soltermann, S. Raeppel, L. Macdonagh, M. Melovic, H. Lambkin, B. Stanfill, D. Nonaka, C.M. Goparju, B. Murer, D.M. O'Donnell, L. Mutti, Martin P Barr, Stephen P Finn, S. Cuffe, Harvey I Pass, Kenneth Obyrne, I. Schmitt-Opitz, A.T. Byrne
- Abstract
Loading...
-
+
MA 04 - Advocacy: Listen to the Patients
- 11:00 - 12:30
- 10/16/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Patient Advocacy
- Moderators:Rudolf M Huber, C.L. Dégi
-
+
MA 04.10 - An Assessment of the Willingness to Provide Serial Bio-Specimens: Experience from an Irish Tertiary Cancer Centre
12:00 - 12:05 | Presenter: Anne-Marie Baird | Author(s): N.M. Keegan, Martin P Barr, S. Fishleder, A.F. Idris, E. Harrold, P. O'Kelly, E. Duff, S. Lim, M. O'Donnell, D.J. Gallagher, C. Grant, J. Kennedy, D.M. O'Donnell, S. Sukor, C.P. O'Brien, Stephen P Finn, S. Cuffe
- Abstract
Loading...
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-048 - Survival Correlation Between TP53 Gene and PD-L1 Tumour Expression in Resected Non-Small Cell Lung Carcinoma
09:30 - 09:30 | Presenter: Jane Sze Yin Sui | Author(s): M.Y. Teo, S. Twomey, S. Rafee, J. McFadden, K. Gately, Martin P Barr, Steven G. Gray, B. Hennessy, Kenneth Obyrne, S. Cuffe, Stephen P Finn
- Abstract
Loading... -
+
P2.02-064 - A Novel 5-miR Signature Shows Potential as a Diagnostic Tool and as a Predictive Biomarker of Cisplatin Response in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, M. Gallagher, B. Ffrench, C. Gasch, V. Young, R. Ryan, S. Nicholson, N. Leonard, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P2.02-069 - Targeting Neuropilin-1 in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): G. Pidgeon, Steven G. Gray, K. Gately, E. Hams, P.G. Fallon, S. Cuffe, Stephen P Finn, Kenneth Obyrne
- Abstract
Loading...